ChemoMetec Financials
| CHEMM Stock | DKK 480.00 0.40 0.08% |
ChemoMetec |
Understanding current and past ChemoMetec Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of ChemoMetec's financial statements are interrelated, with each one affecting the others. For example, an increase in ChemoMetec's assets may result in an increase in income on the income statement.
Please note, the presentation of ChemoMetec's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ChemoMetec's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ChemoMetec's management manipulating its earnings.
ChemoMetec Stock Summary
ChemoMetec competes with Novo Nordisk, AP Mller, AP Mller, DSV Panalpina, and Orsted AS. ChemoMetec AS engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company was founded in 1997 and is headquartered in Allerd, Denmark. ChemoMetec operates under Medical Equipment classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 155 people.| Foreign Associate | USA |
| Instrument | Denmark Stock View All |
| Exchange | Copenhagen Exchange |
| ISIN | DK0060055861 |
| Business Address | Gydevang 43, Allerd, |
| Sector | Life Sciences Tools & Services |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | chemometec.com |
| Phone | 45 48 13 10 20 |
| Currency | DKK - Danish Krone |
You should never invest in ChemoMetec without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of ChemoMetec Stock, because this is throwing your money away. Analyzing the key information contained in ChemoMetec's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
ChemoMetec Key Financial Ratios
ChemoMetec's financial ratios allow both analysts and investors to convert raw data from ChemoMetec's financial statements into concise, actionable information that can be used to evaluate the performance of ChemoMetec over time and compare it to other companies across industries.| Return On Equity | 0.49 | |||
| Return On Asset | 0.31 | |||
| Target Price | 1000.0 | |||
| Number Of Employees | 162 | |||
| Beta | 1.37 |
ChemoMetec Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining ChemoMetec's current stock value. Our valuation model uses many indicators to compare ChemoMetec value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ChemoMetec competition to find correlations between indicators driving ChemoMetec's intrinsic value. More Info.ChemoMetec AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.64 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ChemoMetec AS is roughly 1.56 . Comparative valuation analysis is a catch-all model that can be used if you cannot value ChemoMetec by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for ChemoMetec's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.ChemoMetec AS Systematic Risk
ChemoMetec's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. ChemoMetec volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on ChemoMetec AS correlated with the market. If Beta is less than 0 ChemoMetec generally moves in the opposite direction as compared to the market. If ChemoMetec Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one ChemoMetec AS is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of ChemoMetec is generally in the same direction as the market. If Beta > 1 ChemoMetec moves generally in the same direction as, but more than the movement of the benchmark.
ChemoMetec November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of ChemoMetec help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ChemoMetec AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of ChemoMetec AS based on widely used predictive technical indicators. In general, we focus on analyzing ChemoMetec Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ChemoMetec's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.65 | |||
| Information Ratio | 0.0699 | |||
| Maximum Drawdown | 33.74 | |||
| Value At Risk | (3.81) | |||
| Potential Upside | 7.03 |
Complementary Tools for ChemoMetec Stock analysis
When running ChemoMetec's price analysis, check to measure ChemoMetec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ChemoMetec is operating at the current time. Most of ChemoMetec's value examination focuses on studying past and present price action to predict the probability of ChemoMetec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ChemoMetec's price. Additionally, you may evaluate how the addition of ChemoMetec to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |